NGO/CS Archives - Page 28 of 43

May 13, 2021March 18, 2022

Meet Kashif Pirzada: Shilling For More Lockdown Measures, While He Has Interests On The Side

Kashif Pirzada is frequently on the media circuit, telling people to be afraid. He openly calls for more restrictions, forced masks, forced testing and more. He openly admits that necessary preventative care is being put off, but he supports doing it anyway.

Kashif Pirzada is yet another “expert” making the rounds on the media circuit. He promotes vaccines, pharmaceuticals, masks, lockdowns, travel restrictions and other measures of medical tyranny. He’s an Associate Professor at McMcaster University, and a graduate of the University of Toronto, and former Lecturer and Governor there. Pirzada has many interesting connections that need looking into.

Let’s start off with his school, McMaster University, which is located in Hamilton. What can we find out there?

1. Pirzada A Professor At McMaster University

Link to search IRS charity tax records:
https://apps.irs.gov/app/eos/

Let’s clarify here: there are actually 2 separate entities. The Foundation is the group that distributes money to various organizations and institutions. The Foundation Trust, however, is concerned primarily about asset management.

BILL & MELINDA GATES FOUNDATION
EIN: 56-2618866
gates.foundation.taxes.2016
gates.foundation.taxes.2017
gates.foundation.taxes.2018

BILL & MELINDA GATES FOUNDATION TRUST
EIN: 91-1663695
gates.foundation.trust.taxes.2018

McMaster University has been receiving large donations from the Bill & Melinda Gates Foundation in recent years. According to the Foundation’s own records, the school got some $21 million from 2015 to 2019. This isn’t to say for sure that the people are compromised, but that is a lot from just one group.

McMaster publicly claims to have isolated the virus that causes Covid-19. That that sounds impressive, it doesn’t hold up to scrutiny. The organization, Fluoride Free Peel, served McMaster with a freedom of information request to access those records. Apparently, they don’t actually exist.

2. Pirzada Part Of NGO: Masks4Canada

Pirzada is part of the group Masks4Canada, which openly calls for mandatory masks on people. All in the name of “science” of course. Several prominent names are also there, including professional speaker Abdu Sharkawy.

We are a grassroots volunteer group of physicians, media, data scientists, marketing specialists, technologists, lawyers, engineers, students, teachers, parents, and advocates. We provide expertise and time in advocating for our cause, and our initiative is based on scientific research.

Our mission is to inform and educate all levels of the Canadian government and the public about the critical role of masks and/or face coverings in reducing the transmission of COVID-19. Mandatory masking in high-risk settings, in addition to physical distancing and hand hygiene, will help save lives and the economy.

We do not sell masks or medical supplies. We do not endorse or partner with any for-profit companies or organizations, nor will we receive or ever receive any funding from a foundation, corporation, union, registered third party association, or political group.

It’s not bad enough that this group wants force masks on everyone, including children. They openly call for full blown tyranny. Consider this April 12, 2021 letter:

We need national standards, either as a condition of receiving federal money or, if necessary, imposed under an order or regulation under the various existing federal acts referenced above. In particular, we need national standards governing:

1. Metrics-driven restrictions. We need national standards that use critical metrics such as reproduction rate
(R), test positivity, and healthcare capacity to trigger the imposition or lifting of restrictions on the opening
of businesses, schools, and other publicly accessible spaces. These metrics should be made public and
trackable.

2. Consistent travel restrictions. International, interprovincial, and interregional travel should be permitted only between areas where there are similarly low levels of COVID-19 cases and these restrictions need to be consistently enforced so as to avoid constant re-introduction of new cases. Quarantine protocols for essential travel between provinces should be standardized

3. Consistent responses to exposures.
a. Isolation: We need national standards for the duration of self-isolation for patients who had an exposure or are diagnosed with COVID-19. These standards may need to change in response to variants.
b. Sick Days: We also need nationally mandated paid sick days for essential workers to support time off for vaccination or testing as well as self-isolation as needed, as these groups are driving infections in the third wave.

4. Masking. Masking needs to be mandatory in public indoor spaces, including all schools and workplaces, regardless of distancing. This mask mandate should be supported by clear and consistent mask quality requirements (e.g. ASTM certification) and the distribution of N95 or equivalent masks to the Canadian population.

5. Testing. We need to expand and normalize the use of mass rapid testing as a screening tool in schools, workplaces, and health care facilities, and make rapid testing widely available to the general public. Such uses should be consistent across Canada.

6. Aerosol mitigation. ASHRAE and PHAC recognize that COVID-19 is primarily an airborne disease. We need national rules about minimum requirements for HVAC systems, air filtration, and indoor air purity, particularly for congregate settings such as LTCs, large workplaces, and our schools using guidelines such as those provided by the Harvard-Chan School of Public Health.

7. Vaccination. National standards are needed to support equitable and effective distribution. Now that elderly and Indigenous populations are largely vaccinated, it should be a national priority to vaccinate essential workers in congregate settings (e.g. school staff, workers in large workplaces), and postal codes with higher proportions of frontline workers.

8. Data. A national database with immunization information and strong privacy protections will be critical to support an effective and efficient rollout to the entire population, including those who do not have legal documentation or move between provinces or territories. Similarly, there needs to be a consistent approach to data collection across provinces, including uniform information classification and data gathering requirements to facilitate cross-jurisdictional data comparison and analysis. This will be of particular importance in following up and tracking outcomes with vaccine recipients.

How did this group go from simply calling for masks, to micromanaging every aspect of people’s lives? They openly call for travel restrictions, but don’t seem to have a problem with people in the country illegally.

3. Pirzada Founds Critical Drugs Coalition

Pirzada helped found the group Critical Drug Coalition. (Interesting that the acronym is CDC). This is supposedly a volunteer group that calls for more access to pharmaceuticals, and for more funding.

This group wants various Governments to: (a) ensure more transparency and clearer communication around essential drug supply. The drugshortages.ca website run by the Federal Government needs to be made more usable for front-line pharmacists managing drug shortages; (b) encourage domestic manufacturing capacity especially of vaccines and other critical care drugs; and (c) commit to an Critical Medications List which the government commits to ensure are always in stock through the National Emergency Stockpile.

While this may sound fine on the surface, all of the members have ties to the medical and/or pharmaceutical industries. Calling them “volunteers” is misleading, as they would stand to financially benefit from increased amounts of money from Ottawa and the Provinces.

4. Pirzada Owns EasyFit Online Exercise

Pirzada has another side business, EasyFit. It’s an online fitness business which will allow doctors to make prescriptions and monitor activity without physically visiting the office.

FOR USERS: a platform that allows them to access a virtual trainer marketplace, monitor their exercise and diet plans, compete with their friends during live group video workouts, high-quality free fitness content, and to receive personalized exercise programs prescribed by their doctors.
.
FOR DOCTORS: a platform that allows them to prescribe and monitor evidence-based exercises to their patients using our intelligent exercise prescription algorithm, without resorting to opioids and other dangerous therapies.
.
FOR COACHES: a platform that allows them to manage online clients and build their brand using industry-leading program builders, live video training capability, in-app messaging, auto billing and more tools to scale their business as virtual trainers.

On the surface, there is nothing wrong with such an application. After all, the vast majority of people would benefit from extra exercise. However, it’s quite the coincidence that this business would grow as a result of the same lockdowns and restrictions that Pirzada supports.

5. Pirzada And Conquer Covid

Part of this was addressed in an earlier piece, but Pirzada hadn’t been focused on. Although the website is now deleted, he was (is?) part of Conquer Covid NGO. This is a group selling merchandise. The sales of the merchandise were to be used to purchase PPE for health care workers. Of course, none of this would ever be skimmed or disappear.

The organization was promoted by Doug Ford, in one of his usual cringeworthy press conferences. But he has to at least look the part.

Conquer Covid seems to have dropped off the public radar. Party this is because the commercialization and mass production of PPE has taken off. Partly it’s because goodwill seems to have disappeared.

It’s unclear exactly how much Pirzada directly profits from these enterprises. However, it appears obvious that he enjoys the limelight, and being an “expert” that people turn to. Like so many other times, a nobody is vaulted into public prominence.

6. Other Bits Of Information

Pirzada also follows Bill Gates online, according to his LinkedIn page. That makes sense, considering how much he’s donated to McMaster University in recent years.

Pirzada is also part of Ontario’s Consent and Capacity Board. His job was reviewing cases of people involuntarily detained in the mental health system. Previously, he was a coroner with the Ministry of Corrections (prisons). What an interesting backround.

He’s also been a lecturer and former Governor at the University of Toronto. This isn’t just some doctor sharing his expertise. He is very, very well connected.

7. Pirzada On Council For CPS Ontario

Pirzada is also on the Council for the College of Physicians and Surgeons for Ontario, which licenses doctors in the Province. Recently, the CPSO threatened to pull the licenses of any doctors engaging in “misinformation”. After a lot of backlash, they claimed it wasn’t meant to stifle debate.

8. Pirzada Just Tip Of The Iceberg

And no, this corruption isn’t limited to one person, or one institution. The entire system, including the Ontario Science Table, is rotten to the core.

Michael Warner is head of the Canadian Division of askthedoctor.com. Kumar Murty of OST runs a technology company called PerfectCloudIO, which stands to profit from lockdowns. Kwame McKenzie of OST led the research into the 2017 UBI project in Ontario. And on a related note: Trillium Health Partners got a $5 million gift from a company that makes face masks. Abdu Sharkawy makes a small fortune on the speaking circuit. Robert Steiner of OST, an LPC operative, claims to be the brains of PHAC, founded in 2004. Ryan Imgrund shills for lockdowns while his employer fundraises money. Isaac Bogoch is in the UofT club, is part of Ontario’s “Operation Warp Speed”, and pretends to be neutral.

May 10, 2021January 27, 2022

CV #24(D): Heidi Larson; LSHTM; VCP; Vaxxing Pregnant Women; Financed By Big Pharma

Heidi Larson is a bit of a superstar for the pharmaceutical industry, and its allies. It’s well known that GAVI, the Global Alliance for Vaccines and Immunization, is heavily funded by the Gates Foundation, and big pharama. GAVI has also been lobbying the Canadian Parliament for years, and getting hundreds of millions of dollars in grants.

A bit of background information here. The VCP, Vaccine Confidence Program, is part of the LSHTM, or London School of Hygiene & Tropical Medicine. Both receive extensive funding from pharmaceutical companies, the Bill & Melinda Gates Foundation, the World Health Organization, and Governments.

Who else is worth noting?

Board member, Carlos Alban (AbbVie)
Board member, Bill Anderson (Roche)
Board Member, Gabriel Baertschi (Grünenthal)
Board member, Anders Blanck (LIF)
Board Member, Olivier Charmeil (Sanofi)
Board Member, Alberto Chiesi (Chiesi)
Board member, Frank Clyburn (MSD)
Board Member, Eric Cornut (Menarini)
Board member, Richard Daniell (Teva Pharmaceutical Europe)
Board member, Johanna Friedl-Naderer (Biogen)
Board Member, Murdo Gordon (Amgen)
Board member, Peter Guenter (Merck)
Board member, Angela Hwang (Pfizer)
Board member, Enrica Giorgetti (Farmindustria)
Board member, Dirk Kosche (Astellas)
Board member, Jean-Luc Lowinski (Pierre Fabre)
Board member, Catherine Mazzacco (LEO Pharma)
Board member, Johanna Mercier (Gilead)
Board member, Luke Miels (GSK)
Board member, Gianfranco Nazzi (Almirall)
Board member, Oliver O’Connor (IPHA)
Board Member, Stefan Oelrich (Bayer)
Board member, Giles Platford (Takeda)
Board member, Antonio Portela (Bial)
Board member, Iskra Reic (AstraZeneca)
Board Member, Susanne Schaffert (Novartis)
Board member, Stefan Schulze (VIFOR PHARMA)
Board Member, Kris Sterkens (Johnson & Johnson)
Board member, Han Steutel (vfa)
Board member, Alfonso Zulueta (Eli Lilly)

One of the major donors of the Vaccine Confidence Project is the European Federation of Pharmaceutical Industries and Associations (EFPIA). It’s Board is made of up members representing major big pharma companies.

Another donor of VCP is the Innovative Medicine Institute. Salah-Dine Chibout is on the Governing Board of IMI, and also is the Global Head of Discovery and Investigational Safety at Novartis. Additionally, Paul Stoffels is the Chief Scientific Officer at Johnson & Johnson, Worldwide Chairman of Janssen Pharmaceutical Companies of Johnson & Johnson.

The VCP also works closely with the World Health Organization, and is supportive of its mass vaccination agenda. The role with WHO is simply to market the programs to make them more effective.

The Gates Foundation has financial connections to WHO, GAVI, the CDC, and countless pharmaceutical companies. It is also connected to agencies that are involved in computer modelling, such as:
(a) Imperial College London, Neil Ferguson
(b) London School of Hygiene & Tropical Medicine
(c) Vaccine Impact Modelling Consortium

While all of this is nefarious and creepy, where does Heidi Larson fit into this? What role does she play in the system?

Larson works for both VCP and LSHTM. Her job is mostly one of research and consulting into “increasing vaccine confidence”. In layman’s terms, she is looking into ways to convince segments of the population to get vaccines at higher rates. This doesn’t involve research into CREATING safer and more effective products. Instead, it’s done to CONVINCE people that they already are. Her financial connections to companies like GSK and Merck likely influence her work.

Larson and her cronies apparently see nothing wrong with targeting pregnant women, who are the focus of the following article. Yes, damn the consequences, let’s vaxx the preggers. This, and the following information should horrify and enrage normal people.

5. Conclusion
This literature review has shown that both pregnant women and HCW cite safety concerns as a main barrier to obtaining/providing influenza and pertussis vaccines during pregnancy. However responses differed depending on geographical area: inlow-income countries for example, pregnant women were more likely to cite access issues as a barrier to vaccination. There are alsowide gaps in knowledge regarding the attitudes of HCW to vaccination in pregnancy, which is significant considering the impact they have on a woman’s decision to vaccinate.
.
From the supply side, regulatory agencies still do not have a licensing pathway for many vaccines for pregnant women, manufacturers remain concerned about liability and providers perceive that pregnant women are unwilling to accept vaccines [95].
.
As the MDG era comes to an end, the development agenda beyond 2015 is widening to include other important health issues such as non-communicable diseases (NCDs). However, neither still-births nor neonatal deaths are mentioned in post-2015 documents [96] risking that the current momentum for new-born health may be lost.
.
Barriers to vaccination in pregnancy are complex and can differ from barriers and concerns affecting uptake of routine childhood vaccinations. Maternal vaccination is administered at a time when the patient is cautious about various behaviours, including taking medications and vaccinations, and feels responsible for not just her own life but of that foetus. Depending on the cultural context, different norms are also established around the time of pregnancy. Barriers also vary depending on context and target population.
.
Taking these points into account, ‘quick-fix’ interventions which aim to increase vaccination uptake, such as health communication messages and training physicians in communication strategies [97], without understanding addressing the root cause of vaccine hesitancy in specific contexts, are likely to have little effect on patients’ decisions to vaccinate or on the provider’s own confidence in communicating with parents about vaccines.
.
It is important to understand how cultural and gender dynamics in different settings can influence a woman’s decision to vaccinate. This can be done through in-depth local ethnographies, taking the views of all community members and influencers into account, complemented by in-depth individual interviews and focus groups. Research could also examine some of the complex socio-political reasons for under-vaccination in certain communities must to inform vaccination policies and delivery strategies. With more understanding of the perspectives of pregnant women, their providers and communities, maternal vaccine strategies will be more likely to reach and protect pregnant women and their newborns from preventable disease.

Rather than reading the entire paper, that’s the conclusion. First, it’s pointed out that vaccine manufacturers are concerned about liability. So they are fully aware of the damage and exposure their products can bring. Second, it’s acknowledged that women feel responsibility for not just themselves, but the baby as well. This can be manipulated and it ties into the third point, that specific messaging needs to be used on this group. Fourth, specific training to “sell” the vaccines will likely be needed. Fifth, it is higher vaccination rates, not overall safety, that is the focus.

The reference list is extensive.
Check out the actual paper.

That is interesting. Not only is Larson working for the LSHTM and Vaccine Confidence Program, but she has also been employed by pharmaceutical companies GlaxoSmithKline and Merck.

Vaccine confidence concerns the belief that vaccination – and by extension the providers and range of private sector and political entities behind it – serves the best health interests of the public and its constituents. The Oxford English Dictionary defines confidence as “the mental attitude of trusting in or relying on a person or thing”. In light of that, we are not examining the well-studied domain of supply and access barriers to vaccination, but rather what is typically called the “demand” side of immunisation. However, our focus on confidence takes the “demand” rubric a step further than the more traditional notion of building demand through increasing knowledge and awareness of vaccines and immunisation to understanding what else drives confidence in vaccines, and the willingness to accept a vaccine, when supply, access and information are available. In other words, understanding vaccine confidence means understanding the more difficult belief-based, emotional, ideological and contextual factors whose influences often live outside an immunisation or even health programme but affect both confidence in and acceptance of vaccines.

The Vaccine Confidence Program believes that vaccines are good for humanity. It’s a part of the LSHTM, which is one of the biggest modelers of CV-19, predicting death waves. It also receives funding from drug companies who have a product to sell. What we have is a situation where the manufacturers, sales agents, and marketers work together under some humanitarianism guise.

October 2020, Larson co-chaired a panel on combatting pandemic misinformation. It was hosted by LSHTM and Center for Strategic and International Studies.

December 2020, Larson tweeted out — but did not condemn or question — a JAMA Network article discussing mandatory vaccinations.

January 2021, LSHTM tweeted (and Larson retweeted) a Telegraph article on combatting misinformation

January 2021, Larson was at the Pulitzer Center for a talk on combatting misinformation around CV vaccination. A look at their donors reveals the Bill & Melinda Gates Foundation, Facebook, Omidyar Network, Planned Parenthood, and the Rockefeller Foundation.

March 2021, Larson wrote a piece for the New York Times, in support of AstraZeneca. The basic premise was that the AZ vaccine was safe, and that only public perception and confidence were keeping it from being distributed. She also called for “training vaccinators” in such a way to boost the image among others. In short, train people to better sell the product.

Now, this may be a coincidence, but some of the same companies that are paying for Larson’s work “increasing vaccine confidence” are also lobbying Ottawa to buy their products.

Side note with GlaxoSmithKline: Larson has disclosed being a consultant for the company. Now, in 2009, Canada gave Interim Authorization (not approval), to 2 vaccines for H1N1, Arepanrix and Monovalent Vaccine. Lawsuits were filed because the injections harmed a lot of people, but:

[19] The federal Minister of Health authorized the sale of the Arepanrix vaccine pursuant to an interim order dated October 13, 2009. Human trials of the vaccine were still underway. The Minister of Health is empowered to make interim orders if immediate action is required because of a danger to health, safety or the environment. In issuing the interim order, Health Canada deemed the risk profile of Arepanrix to be favourable for an interim order. The authorization was based on the risk caused by the current pandemic threat and its danger to human health. As part of the interim order process, Health Canada agreed to indemnify GSK for any claims brought against it in relation to the administration of the Arepanrix vaccine.

That’s one way to have high confidence in your product: make any sale contingent on getting legal immunity in advance. It’s fair to assume this latest batch came with the same conditions.

Larson’s career appears to have taken off in 2000, then she went to work for UNICEF. No surprise, but she was pushing mass vaccination even then. The bulk of her career appears to be acting as a mouthpiece for big pharma.

Canada announced the launch of a vaccine injury compensation program in December 2020, but so far, so follow-ups have been mentioned.

An interesting side note with Larson’s Twitter profile: she claims that she “did this reluctantly”. That is a strange comment. Does she not believe in what she pushes on the global population?

Anyhow, if nothing else is taken away from here, remember this: the “vaccine confidence” movement is funded by big pharma. They want to convince you that their products are safe. Just ignore the testing issues, and the indemnification agreements.

(1) https://www.vaccineconfidence.org/
(2) https://www.vaccineconfidence.org/team
(3) https://www.vaccineconfidence.org/partners-funders
(4) https://archive.is/Ah9Pw
(5) https://www.efpia.eu/
(6) https://www.efpia.eu/about-us/who-we-are/
(7) https://www.imi.europa.eu/about-imi/governance/governing-board
(8) https://www.who.int/vaccine_safety/initiative/communication/network/vaccineconfidenceproject/en/
(9) Vaccination During Pregnancy Propaganda Research
(10) Vaccine Acceptance During Pregnancy Research
(11) https://www.vaccineconfidence.org/vcp-mission
(12) https://twitter.com/ProfHeidiLarson
(13) https://www.linkedin.com/in/heidi-larson-07b535119/
(14) https://www.csis.org/analysis/call-action-csis-lshtm-high-level-panel-vaccine-confidence-and-misinformation
(15) https://jamanetwork.com/journals/jama/fullarticle/2774712?utm_source=twitter&utm_campaign=content-shareicons&utm_content=article_engagement&utm_medium=social&utm_term=122920#.X-uxuv4Z2-I.twitter
(16) https://www.telegraph.co.uk/global-health/climate-and-people/meet-scientists-tackling-vaccine-misinformation-tiktok/
(17) https://pulitzercenter.org/event/covid-19-vaccines-combating-misinformation
(18) https://pulitzercenter.org/about/donors
(19) https://www.nytimes.com/2021/03/22/opinion/astrazeneca-vaccine-trust.html
(20) https://lobbycanada.gc.ca
(21) https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/legislation-guidelines/interim-orders.html
(22) https://www.canlii.org/en/on/onsc/doc/2019/2019onsc7066/2019onsc7066.html
(23) https://en.wikipedia.org/wiki/Heidi_Larson
(24) https://www.canada.ca/en/public-health/news/2020/12/government-of-canada-announces-pan-canadian-vaccine-injury-support-program.html

CANUCK LAW ON “VACCINE HESITANCY”
(A) Canada’s National Vaccination Strategy
(B) The Vaccine Confidence Project
(C) More Research Into Overcoming “Vaccine Hesitancy”
(D) Psychological Manipulation Over “Vaccine Hesitancy”
(E) World Economic Forum Promoting More Vaccinations
(F) CIHR/NSERC/SSHRC On Grants To Raise Vaccine Uptake
(G) $50,000 Available — Each — For Groups To Target Minorities
(H) Canada Vaccine Innovation Community Challenge

May 6, 2021November 10, 2024

Meet Éric Lamoureux Of Public Affairs Advisors, Puppet-Master Of Francois Legault On SNC Lavalin

In February 2019, Quebec Premier Francois Legault called on the Federal Government to make a deal with SNC Lavalin in the ongoing criminal case. Presumably, that meant offering Lavalin a Deferred Prosecution Agreement, or DPA. This would allow them to continue bidding on Federal contracts immediately, and bypass the mandatory 10 year ban. Previously, Quebec had been pressuring Ottawa to change the law to allow for such legislation to be enacted.

The topic of corruption at SNC Lavalin has been addressed in this mini series. Take a read through for more background information.

Now, a question has to be asked: where did Legault get this idea? Who has been pulling his strings?

Éric Lamoureux
Managing Director, Montréal

Éric Lamoureux has been helping Canadian corporate and political leaders effectively manage complex public policy and reputational issues for more than a decade. In that time, he has been a political advisor to leading federal and municipal politicians, national associations, cultural groups, and both national and global corporations.

Based in Montréal, Éric draws on deep expertise in politics and public administration to help clients protect and promote their interests in Canada and Québec. As a specialist in issues management, regulatory affairs, stakeholder relations and media relations, Éric has achieved many notable successes on behalf of his clients, including: helping a global financial services company safeguard its market position in the face of regulatory change; mobilizing the support of a provincial government to pressure for changes to the federal Criminal Code on a client’s behalf; and encourage a major Canadian municipal government to reverse a decision to construct a public building beside a client facility.

As Managing Director based in Montréal, Éric leads all of the firm’s activities and operations in Québec, and works with clients on issues across Canada.

Meet Éric Lamoureux Of Public Affairs Advisors, PPA, a lobbying firm that operates out of Quebec and Ottawa. While he doesn’t name SNC Lavalin, perhaps to make it less obvious, who else could it be?

The implication is that Lamoureux and PPA lobbied the Quebec Government to pressure the Federal Government to change the law. This would have allowed Lavalin to escape the worst of potential criminal sanctions. If this isn’t illegal, at a minimum it’s incredibly sleazy.

It takes a special kind of stupid to announce corruption in your professional profile. Then again, in this atmosphere, it may just be a form of advertising.

According to his LinkedIn page, Lamoureux worked for the Liberals from 2003 to 2006. Keep in mind, this is the period that Jean Chretien was forced to resign (because of corruption allegations). Later, Paul Martin was voted out of office (because of corruption allegations). Afterwards, Lamoureux became the Chief of Staff for the Ottawa Mayor.

So why not just lobby Ottawa directly? Well, that was done as well, primarily by Bruce Hartley (a Chretien operative), and William Pristanski (a Mulroney operative). Check earlier pieces in the series. Lamoureux and PPA were just another level of pressure, trying to get Quebec to pile on with the Federal Liberals.

Now, it’s possible that Lamoureux is just puffing his chest, and he isn’t the mastermind. But then, why brag about something like this? It’s strange that his name doesn’t appear anywhere in the mainstream press about this “accomplishment”.

Looking through the index of advisors, it’s clear that these are political hacks (of different Parties), who come together to peddle influence for whoever happens to pay their bills.

Felix Wong is an Advisor in PAA’s Ottawa office with nearly a decade of political experience and a strong background in communications, public policy, issues management and stakeholder engagement.
.
Felix understands the government decision-making process, having worked in various roles on Parliament Hill, including as an advisor to several Cabinet Ministers. In addition, he served as Manager of National Outreach for the Conservative Party of Canada and has been a part of two national election campaign teams for the Conservatives. In these roles, he helped create a stakeholder outreach strategy to communicate policies to Canada’s diverse cultural communities.

Maryanne Sheehy is an Advisor in Ottawa providing strategic analysis, public policy, media, and stakeholder relations advice to clients.
.
Maryanne has an in-depth knowledge of government having worked in the Prime Minister’s Office in Ottawa for over five years where she served in a variety of roles including as an Advisor for stakeholder relations and outreach. She brings expertise in developing and implementing communications, stakeholder, and issues management strategies for key business and political decision makers. During her time on Parliament Hill, Maryanne also worked as an Advisor to the Prime Minister’s Chief of Staff and was part of two national campaign teams for the Conservative Party of Canada.

Not to worry, this isn’t just a problem of Liberal cronyism. At least at few advisors at PPA has ties to the higher ups on the Conservative Party of Canada.

Latitia Scarr is a Senior Advisor & Client Director in Ottawa, where she brings extensive experience in policy, government relations and communications. Most recently, she worked for the Canadian Produce Marketing Association, managing advocacy and regulatory issues affecting trade.
.
Previous roles have included Caucus Services in the Liberal Research Bureau/Office of the Leader of the Opposition and Policy Manager at the Liberal Party of Canada National Office. These and other positions have given her wide-ranging knowledge on issues such as trade, agriculture and food, public safety, health, customs, innovation, Indigenous affairs, natural resources, among others, as well as of the public policy arena.

Bit of a side note: she also worked for the coalition for gun control. Now she works with so-called conservatives. How peculiar.

Dan Pfeffer is a Senior Advisor & Client Director in Ottawa, working with the firm’s clients at the federal, provincial and municipal levels of government. Based in Ottawa, he holds a Ph.D. in political science and has researched and published on various aspects of public policy and government decision making. He also has taught in faculties of various universities including McGill and l’Université du Québec à Montréal.
.
Dan brings extensive knowledge of group mobilization and stakeholder engagement to his work on behalf of clients in the health, technology, financial services and telecommunications sectors. In addition to his academic work, he served as a key member of the campaign team that elected Anthony Housefather in the hotly contested federal riding of Mount Royal in 2015.

Pfeffer taught at McGill University. That is a strange coincidence (if it is one) that current Attorney General David Lametti is a Professor there, currently on leave. Lametti was brought in as the “fixer” after Jody Wilson-Raybould refused to grant SNC Lavalin their DPA.

Noah Niznick is a Senior Advisor & Client Director in Ottawa, where he works closely with clients in the financial services, natural resource and health care sectors. He joined the firm after serving for several years as the senior political advisor to the national caucus chair of Canada’s Official Opposition.
.
In that role, Noah established deep policy knowledge and strong relationships with elected officials, government advisors, as well as the many stakeholders engaged in public policy at the federal level. He has developed significant policy initiatives on a range of economic, consumer, and technology issues, working with a range of diverse interests. He also manages traditional and social media strategies, as well as issue-focused communications campaigns to reach targeted audiences.

Michael von Herff founded the firm in 2010 and works with clients to advance their public policy and regulatory agendas in Canada, the United States and Europe.
.
Over the past 25 years, Michael has helped clients protect and promote their interests with governments, media and stakeholders on the issues that matter most to their business. He has delivered success on a range of challenging assignments including: convincing a U.N. body to pass new regulations to accommodate the concerns of one of the world’s most important commodity groups; securing $100 million in new government support for a research fund in a previously ignored disease area; and, ensuring a major Canadian services company did not become a victim of policy change during a major overhaul of financial services regulations.

Other than political cronyism, what else are these people up to these days? Who’s writing the cheques now?

Seems that Public Affairs Advisors is now lobbying on behalf of Moderna. After all, Canadians need those interim authorized (not approved), mRNA vaccines to be distributed immediately. Seems that the PPA really will represent anybody. We’ll have to see what else comes their way.

May 5, 2021July 6, 2022

Canada Pension Plan Investment Board, And Some Of Their Holdings

The Canadian Pension Plan Investment Board is responsible for investing the money that gets taken from workers’ pay cheques. Now, what does this group actually invest in? The answers may be surprising, as it speaks to the direction they plan to take the fund.

COMPANY	AMOUNT
3M Co.	$51,203,000
Acceleron Pharma Inc.	$85,000
Agios Pharmaceuticals Inc.	$1,017,000
Alexion Pharmaceuticals	$33,800,000
Alnylam Pharmaceuticals	$1,329,000
Amicus Therapeutics	$31,186,000
Arrowhead Pharmaceuticals	$69,000
Biogen	$3,749,000
Biohaven Pharmaceuticals	$31,000
China Biologic Products	$242,000
CVS Health Corp.	$104,361,000
Cardiovascular Sys Inc.	$1,339,000
Checkmate Pharmaceuticals	$219,000
Eli Lilly & Co.	$134,902,000
Fusion Pharmaceuticals	$36,624,000
GW Pharmaceuticals	$173,115,000
Gilead Sciences	$85,944,000
HCA Healthcare	$20,325,000
Healthpeak Properties Inc.	$43,159,000
Horizon Therapeutics	$688,000
Hutchison China Meditech	$3,145,000
Ionis Pharmaceuticals	$2,414,000
Johnson & Johnson	$479,225,000
Ligand Pharmaceuticals	$466,000
Magellan Health	$5,683,000
Medifast Inc.	$641,000
Medpace Holdings Inc.	$15,813,000
Merck & Co.	$379,344,000
Mirati Therapeutics	$61,000
Moderna	$75,193,000
Neurocrine Biosciences	$752,000
Novavax Inc.	$56,000
Opko Health Inc.	(Sold off)
Orthofix Med Inc.	$976,000
PTC Therapeutics	$13,561,000
Pacira Biosciences	$13,925,000
Pfizer Inc.	$224,969,000
Phillip Morris	$128,347,000
Physicians Realty Trust	$5,618,000
Prestige Consumer Healthcare	$1,022,000
Procter & Gamble	$498,019,000
Quest Diagnostics	$130,317,000
Reata Pharmaceuticals	$323,000
Regeneron Pharmaceuticals	$3,233,000
Royalty Pharma	$5,420,000
Sabra Healthcare REIT	$6,232,000
Sage Therapeutics	$735,000
Sigilon Therapeutics	$71,333,000
Starr Surgical Co.	$21,247,000
Teladoc Health Inc.	$4,796,000
Tenet Healthcare Corp.	$14,267,000
Teva Pharmaceuticals	$1,723,000
Theravance Biopharma	$169,000
Thermo Fisher Scientific	$198,939,000
Trevi Therapeutics	$36,000
Trillium Therapeutics	$1,431,000
Ultragenyx Pharmaceutical	$1,000
United Therapeutics Corp.	$413,000
Unitedhealth Group Inc.	$1,067,720,000
Usans Health Sciences	$5,867,000
Viatris Inc.	$16,153,000
West Pharmaceutical SVSC	$410,000
Zimmer Biomet	$19,398

Aside from all of the stocks in pharmaceuticals and health care, the CPPIB has interests in many other organizations that will raise eyebrows. True, the “Great Reset” may be a massive conspiracy theory, but the investments here would suggest otherwise.

COMPANY	AMOUNT
Alphabet Inc.	$2,188,964,000
Amazon Inc.	$779,986
American Express	$134,979,000
Apple Inc.	$979,811,000
Aramark	$19,240,000
Autodesk	$19,044,000
Bank of America	$372,509
Bank of Montreal	$62,350
Bank of Nova Scotia	$216,553,000
Best Buy	$12,943,000
Blackline Inc.	$493,000
Blackrock	$230,895,000
Blackstone	$53,059,000
Boeing	$70,565,000
Citigroup	$319,809,000
Comcast Corp.	$65,150,000
E-Bay	$15,259,000
Equifax	$135,602,000
Fox Corp.	$4,632,000
Hewlett Packard	$121,000
Home Depot	$274,181,000
Icici Bank Limited	$59,222,000
JP Morgan Chase	$876,096,000
Mastercard Incorporated	$2,236,387,000
Microsoft Corp	$1,143,414,000
Molson Coors Beverage	$8,593,000
NASDAQ	$5,116,000
Newscorp	$470,000
Paycom Software	$993,000
Paychex Inc.	$19,982,000
PayPal Holdings	$228,341,000
Pinterest	$611,000
Rogers Communications	$1,500,000,000
Royal Bank of Canada	$537,548,000
Shaw Communications Inc.	$100,269,000
Shopify	$244,903,000
Starbucks Corp.	$32,580,000
Synchrony Financial	$5,553,000
Target Corp.	$29,903,000
Tesla Inc.	$128,538,000
Toronto Dominion Bank	$289,035,000
Transunion	$37,293,000
Trip Advisor	$1,468,000
Twitter Inc.	$57,887,000
Uber Technologies	$60,382,000
Verizon Communications	$192,559,000
Visa Inc.	$135,000
Vonage Holdings Corp	$145,000
Walmart Inc.	$245,483,000
Zoom Video Communications	$5,807,000

For reference, Alphabet Inc. is the company that owns Google and its subsidiaries, such as YouTube. It seems that being major stakeholders in the business will have great influence over the social media censorship that Governments ask them to play. CPPIB holds over $2 billion. Difficult to say no to your biggest shareholders.

Additionally the CPPIB holds over $50 million in stock in Twitter. This platform has also been brutal when it comes to censoring views that contradict official pandemic or election narratives.

This is certainly quite in the interesting portfolio: pro-big pharma, and pro-Great Reset. However, there is a bigger and more fundamental problem that needs to be addressed: liabilities.

Year	Value of Fund	Inv Income	Rate of Return
2010	$127.6B	$22.1B	14.9%
2011	$148.2B	$20.6B	11.9%
2012	$161.6B	$9.9B	6.6%
2013	$183.3B	$16.7B	10.1%
2014	$219.1B	$30.1B	16.5%
2015	$264.6B	$40.6B	18.3%
2016	$278.9B	$9.1	6.8%
2017	$316.7B	$33.5B	11.8%
2018	$356.B	$36.7B	11.6%
2019	$392B	$32B	8.9%

The CPPIB routinely crows about how well its investments do, and how the fund is worth hundreds of billions of dollars. The problem is that it has a screwy accounting system. Instead of taking into account all assets and liabilities, the health is determined by ability to meet current obligations. The fund has been properly accounted, and there is over $1 trillion in unfunded liabilities. This is money taken in an spent, for which it (should have been) paid out.

Most pension systems act as a ponzi scheme, where the only way to meet old obligations is with the infusion of new money. Clearly, such a system is unsustainable in the long term.

But hey, at least our investments in Pfizer, Moderna, Johnson & Johnson, Gilead, Eli Lilley and 3M are doing well. Good thing there is a “pandemic” to drive up demand for these products.

To hell with free speech and open media.
Big pharma is here to stay.

https://www.sec.gov/edgar/browse/
https://www.sec.gov/edgar/browse/?CIK=1283718
https://www.sec.gov/Archives/edgar/data/1283718/000110465921024475/xslForm13F_X01/infotable.xml
https://www.cppinvestments.com/the-fund/our-performance
https://canucklaw.ca/pensions-1b-unsustainable-underfunded-takes-money-out-of-canada/

May 5, 2021November 21, 2021

Ontario Teachers Pension Plan, And The Interesting Stocks They Own

https://twitter.com/ETFOeducators/status/1371865858046365704

The Elementary Teachers Federation of Ontario (ETFO) has publicly called for forcing masks on children, even those in kindergarten. However, not everything is as it appears. For example, the OTPP, the Ontario Teachers Pension Plan, owns $83 million in stock in 3M. This is a company that makes masks.

Also, an honourbale mention and shoutout to Stormhaven, who has covered this, and taken a different approach. Check that piece out as well, as it has lots of good information.

What else is in the OTPP (which includes both elementary and high school teachers)? Information on the holdings can be obtained for free at the U.S. SEC, the Securities and Exchanges Commission.

COMPANY	AMOUNT
3M CO	$83,000,000
Abbott Labs	$355,000
Biogen Inc.	$41,915,000
Eli Lilly & Co	$1,110,000
Gilead Sciences	$1,406,000
Globeus Med Inc.	$513,000
Jazz Pharmaceuticals PLC	$317,000
Johnson & Johnson	$84,386,000
Medpace Holdings Inc.	$393,000
Merck & Co.	$406,000
Mersana Therapeutics	$504,000
Moderna Inc.	$970,000
Pfizer	$599,000
Procter & Gamble	$837,000
Regeneron Pharmaceuticals	$736,000
Sarpeta Therapeutics	$753,000
TEVA Pharmaceuticals	$17,487,000
United Therapeutics Corp.	$1,077,000
Vertex Pharmaceuticals	$502,000
West Pharmaceutical SVSC	$797,000

$83 million in 3M, a company that manufactures facemasks. This is one of those things that makes you go “hmmm….”, doesn’t it?

In addition to owning parts of companies involved in health care and pharmaceuticals, the OTPP has other interests in businesses that will also profit from extended lockdowns, and the “Great Reset”. Here are some of them:

COMPANY	AMOUNT
Amazon Group	$287,000
Apple	$1,104,000
Bank of America Corp	$579,000
Black Hills Corp	$322,000
Blackstone Group	$413,000
Costco Wholesale	$943,000
Goldman Sachs	$1,714,000
Home Dept	$81,854
Kroger Co.	$662,000
McDonald’s Corp.	$81,651,000
Microsoft	$244,167,000
PayPal Holdings	$542,000
Pepsico	$853,000
Rogers Communications	$743,000
Shaw Communications	$906,000
Tesla Inc.	$561,455,000
Tri Pointe Group Inc.	$1,118,000
Twitter Inc.	$257,000
Verizon Communications	$860,000
Visa Inc.	$83,780,000
Zoom Video Communications	$392,000

It’s not much of a stretch to see that the OTPP stands to benefit from lockdowns and the “Great Reset”. After all, they are heavily invested in industries and companies that will profit from the current situation.

In addition to owning part of 3M, this Pension Plan also owns considerable stock in Gilead Sciences, Eli Lilly, Merck, Moderna, Pfizer, Teva, and over $84 million in Johnson & Johnson. This could explain their support for the vaccine agenda. Then again, it could all just be a coincidence.

It could also be a coincidence that Jo Taylor, who’s in charge of the OTPP, has ties to the World Economic Forum. Likewise, it may just be happenstance that Mark Wiseman, who runs Blackrock (which owns SNC Lavalin), used to run the CPPIB, and helped set up the OTPP.

Read into it what you will.

(1) https://www.sec.gov/edgar/browse/?CIK=937567
(2) https://archive.is/EFPhz
(3) Submissions At End Of December 2020
(4) https://archive.is/PQnkQ
(5) SEC Filings, Total Pension Fund Assets, December 2020
(6) https://archive.is/SKUga
(7) https://www.weforum.org/agenda/authors/jo-taylor
(8) https://www.weforum.org/people/mark-wiseman

(9) Ontario Teachers, World Economic Forum
(10) Healthcare Of Ontario Pension Plan’s Holdings

May 3, 2021September 6, 2021

CV #66(G): Patty Hajdu Lies: Rigorous Testing WASN’T Required To Get “Vaccines” Onto Market

Canadians are constantly told that these gene therapy “vaccines” are safe, and have undergone strict testing in order to be allowed on the market. But what exactly are those standards? And is it normal practice to include a clause making authorization mandatory?

People should know that if the product injures or kills them, indemnification agreements prevent the manufacturers from getting sued. A vaccine injury compensation program was announced back in December, but appears to have gone nowhere.

As a reminder, Interim Authorization and Approval are quite different, and cannot be used interchangeably.

(a) Approved: Health Canada has fully reviewed all the testing, and steps have been done, with the final determination that it can be used for the general population
(b) Interim Authorization: deemed to be “worth the risk” under the circumstances, doesn’t have to be fully tested. Allowed under Section 30.1 of the Canada Food & Drug Act. Commonly referred to as an emergency use authorization.

If you read the inserts provided by Health Canada (see below), they will all claim to be “authorized under Section 5 of an Interim Order”. Fine, but what is that Order, and what does it actually say?

Issuance
5 The Minister must issue an authorization in respect of a COVID-19 drug if the following requirements are met:

(a) the applicant has submitted an application to the Minister that meets the requirements set out in subsection 3‍(1) or 4‍(2);
(b) the applicant has provided the Minister with all information or material, including samples, requested under subsection 13‍(1) in the time, form and manner specified under subsection 13‍(2); and
(c) the Minister has sufficient evidence to support the conclusion that the benefits associated with the drug outweigh the risks, having regard to the uncertainties relating to the benefits and risks and the necessity of addressing the urgent public health need related to COVID-19.

Several of these “vaccines”, and I use the term loosely, were given Interim Authorization under Section 5 of an Interim Order signed by Health Minister Patty Hajdu on September 16, 2020. The above criteria is all that is required.

Note: Section 5 starts out with “The Minister must” issue and authorization. It’s not that “The Minister should”, or “The Minister may” issue one, but the Minister MUST.

Also, the above requirements are not very strict. 3(1) or 4(2) must be met, along with 13(1) and 13(2). And all that’s needed is the very subjective standard that the “Minister has sufficient evidence to support the conclusion”. It doesn’t specify what, if any, standard there is. The Minister only needs to see is as “worth the risk” given the uncertainties there are.

It’s worth noting that Health Canada doesn’t do the testing themselves. Instead, they rely heavily on the documentation provided. Quite the trust system.

Application for authorization
3 (1) Subject to section 4, an application for an authorization in respect of a COVID-19 drug must be in a form established by the Minister and contain sufficient information and material to enable the Minister to determine whether to issue the authorization, including
.
(a) the applicant’s name and contact information and, in the case of a foreign applicant, the name and contact information of their representative in Canada;
(b) a description of the drug and a statement of its proper name or its common name if there is no proper name;
(c) a statement of the brand name of the drug or the identifying name or code proposed for the drug;
a list of the ingredients of the drug, stated quantitatively;
(d) the specifications for each of the drug’s ingredients;
(e) a description of the facilities and equipment to be used in the manufacture, preparation and packaging of the drug;
(f) details of the method of manufacture and the controls to be used in the manufacture, preparation and packaging of the drug;
(g) details of the tests to be applied to control the potency, purity, stability and safety of the drug;
(h) the names and qualifications of all the investigators to whom the drug has been sold;
(i) a draft of every label to be used in connection with the drug, including any package insert and any document that (j) is provided on request and that sets out supplementary information on the use of the drug;
(k) a statement of all the representations to be made for the promotion of the drug respecting
(i) the recommended route of administration of the drug,
(ii) the proposed dosage of the drug,
(iii) the drug’s indications, and
(iv) the contra-indications and side effects of the drug;
(l) a description of the dosage form that is proposed for the sale of the drug;
(m) evidence that all test batches of the drug used in any studies conducted in connection with the application were manufactured and controlled in a manner that is representative of market production;
(n) in the case of a drug intended for administration to food-producing animals, the withdrawal period of the drug; and
(o) the known information in relation to the quality, safety and effectiveness of the drug.

About part (n), it says “administration to food-producing animals”. Are we to assume that livestock are going to be vaccinated with these substances at some point? Or are we repurposing drugs that were originally meant for them? That’s a bit unsettling.

Application for authorization – foreign drug
4 (1) An application for an authorization in respect of a COVID-19 drug may be based on a comparison to a foreign drug if the sale of the foreign drug is authorized by a foreign regulatory authority on the basis of information submitted to the authority in relation to the quality, safety and effectiveness of that drug.
.
Content
(2) The application must be in a form established by the Minister and contain the following information and material:
.
(a) the information and material described in paragraphs 3‍(1)‍(a) to (d), (f), (j) to (l) and, if applicable, (n);
(b) an attestation, signed and dated by an individual who has authority to bind the applicant in Canada, certifying that the applicant has access to the information referred to in paragraph 3‍(1)‍(o) that was submitted to the relevant foreign regulatory authority in order for the foreign drug to be authorized to be sold;
(c) information that demonstrates that the drug is identical to, and is manufactured, prepared and packaged in the same manner as, the foreign drug;
(d) information that demonstrates that the sale of the foreign drug is authorized by the foreign regulatory authority referred to in paragraph (b); and
(e) any labels that are approved by the foreign regulatory authority referred to in paragraph (b) for use in connection with the foreign drug.

Request for information or material
13 (1) The Minister may request that a person that has submitted an application for an authorization in respect of a COVID-19 drug or the holder of such an authorization provide any information or material, including samples, that is necessary to enable the Minister to determine whether to issue, amend or suspend the authorization.
.
Time, form and manner
(2) The person or holder, as the case may be, must provide the information, material or samples in the time, form and manner specified by the Minister.

Section 3(1) lists what documentation needs to be submitted to get authorization. Section 4(2) contains a few extra steps for foreign drugs. Sections 13(1) and (2) state that information and samples must be provided if demanded.

The standard for Interim Authorization under Section 5 appears to be a fairly low one. Keep in mind, the Minister doesn’t even need to be certain the drugs work as advertised. It just has to be determined to be worth the risk. Not quite what we are told on the news.

As for the basis in the law, Section 30.1 of the Canada Food & Drug Act allows the Health Minister to sign such Orders, if it’s believed, (or claimed to be believed), it’s in the public interest. There is no requirement that the Minister have any appropriate education background, or know what he/she is talking about.

Circling back to the top of Section 5, the Health Minister “must issue an authorization” if the conditions in Section 5 are met?!?! So this isn’t discretionary? Our graphic designer Minister must sign off on this?

It’s also unsettling that this Order allows for drugs originally intended for livestock to be repurposed and tested on humans.

WHO Paper On MANDATORY Vaccination April 13, 2021 (Original)
WHO Paper On MANDATORY Vaccination April 13, 2021 (Copy)
Section 30.1 Canada Food & Drug Act
September 2020 Interim Order From Patty Hajdu
https://www.canada.ca/en/public-health/news/2020/12/government-of-canada-announces-pan-canadian-vaccine-injury-support-program.html
https://covid-vaccine.canada.ca/info/pdf/astrazeneca-covid-19-vaccine-pm-en.pdf
https://covid-vaccine.canada.ca/info/pdf/janssen-covid-19-vaccine-pm-en.pdf
https://covid-vaccine.canada.ca/info/pdf/covid-19-vaccine-moderna-pm-en.pdf
https://covid-vaccine.canada.ca/info/pdf/pfizer-biontech-covid-19-vaccine-pm1-en.pdf

Testing Product Insert AstraZeneca Interim Authorization
Testing Product Insert Janssen Interim Authorization
Testing Product Insert Moderna Interim Authorization
Testing Product Insert Pfizer Interim Authorization

Vaccines Supported For Pregnant Women, Despite No Testing
Vaccines Given “Interim Authorization”, Not Approval. Very Different
Call Centers Wrongly Telling People “Vaccines” Are Approved
Ontario Adds, Then Removes Protections Against “No Jab, No Job”
WHO April 13 Paper: Discussion On Mandatory “Experimental Vaxx”

Category: NGO/CS

Meet Kashif Pirzada: Shilling For More Lockdown Measures, While He Has Interests On The Side